Nirsevimab Uptake in a Pediatric Primary Care Network During the 2023-2024 RSV Season
This cohort study characterizes nirsevimab uptake among infants who did and did not receive the respiratory syncytial virus (RSV) vaccine during the 2023 to 2024 RSV season.
Authors
- Thevaa Chandereng (ORCID: https://orcid.org/0000-0003-4078-9176)
- Sarah Schaffer DeRoo (ORCID: https://orcid.org/0000-0002-4572-8703)
- Tamima Hossain
- Jessica Lazerov
Institutions
- Children's National (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.20440
- Citations
- 5
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 6.77
Funders
- National Institutes of Health